SI
LMAT icon

Sensato Investors’s LeMaitre Vascular LMAT Stock Holding History

Sensato Investors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-72,587
Closed -$2.63M – 100
2018
Q1 		$2.63M Buy
+72,587
New +$2.51M 0.41% 50

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sensato Investors's LMAT Position: Q2 2018 in Review

Sensato Investors sold out of LeMaitre Vascular (LMAT) in Q2 2018, closing a stake of 72,587 shares — an estimated $2.63M sold.

Sensato Investors first reported a position in LMAT in Q1 2018 and held it in 1 quarter. The position peaked at $2.63M in Q1 2018. 166 funds tracked by Wall St. Rank hold LMAT as of Q2 2018.

  • Sensato Investors reported no remaining LeMaitre Vascular position as of Q2 2018 after selling out during the quarter.
  • Sensato Investors sold 72,587 LeMaitre Vascular shares in Q2 2018, an estimated $2.63M.
  • Sensato Investors first reported a position in LeMaitre Vascular in Q1 2018 and held it in 1 quarter.
  • Sensato Investors's LeMaitre Vascular position peaked at $2.63M in Q1 2018.
  • 166 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2018.

Based on Sensato Investors's 13F filing for Q2 2018, filed 14 Aug 2018.